Uveitis Masquerade Syndrome : Typical Symptoms and Presentations
Georg Thieme Verlag KG Stuttgart · New York..
The uveitis masquerade syndrome (UMS) describes a series of malignant diseases that mimic inflammatory conditions without belonging to the group of immune-mediated uveitis entities. The correct diagnosis is often difficult to establish, despite a detailed ophthalmological and general medical history using all imaging modalities and interdisciplinary cooperation. In the case of recurrent inflammation, it is very important to consider an UMS, since any delay in proving the underlying diagnosis and initiating the appropriate therapy may be associated with the risk of systemic spread and consecutive deterioration of the prognosis. Often, after all conservative options have been exhausted, the only remaining option to confirm the correct diagnosis might be an intraocular biopsy. The present work focuses on the leading symptoms, differential diagnoses and clinical signs of UMS.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:237 |
|---|---|
| Enthalten in: |
Klinische Monatsblatter fur Augenheilkunde - 237(2020), 5 vom: 01. Mai, Seite 614-620 |
| Sprache: |
Deutsch |
|---|
| Weiterer Titel: |
Uveitis-Masquerade-Syndrome: Leitsymptome und Krankheitsbilder |
|---|
| Beteiligte Personen: |
Biewald, Eva [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 17.09.2020 Date Revised 17.09.2020 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1055/a-1120-8787 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM31016575X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM31016575X | ||
| 003 | DE-627 | ||
| 005 | 20231225135510.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||ger c | ||
| 024 | 7 | |a 10.1055/a-1120-8787 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1033.xml |
| 035 | |a (DE-627)NLM31016575X | ||
| 035 | |a (NLM)32434245 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a ger | ||
| 100 | 1 | |a Biewald, Eva |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Uveitis Masquerade Syndrome |b Typical Symptoms and Presentations |
| 246 | 3 | 3 | |a Uveitis-Masquerade-Syndrome: Leitsymptome und Krankheitsbilder |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 17.09.2020 | ||
| 500 | |a Date Revised 17.09.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Georg Thieme Verlag KG Stuttgart · New York. | ||
| 520 | |a The uveitis masquerade syndrome (UMS) describes a series of malignant diseases that mimic inflammatory conditions without belonging to the group of immune-mediated uveitis entities. The correct diagnosis is often difficult to establish, despite a detailed ophthalmological and general medical history using all imaging modalities and interdisciplinary cooperation. In the case of recurrent inflammation, it is very important to consider an UMS, since any delay in proving the underlying diagnosis and initiating the appropriate therapy may be associated with the risk of systemic spread and consecutive deterioration of the prognosis. Often, after all conservative options have been exhausted, the only remaining option to confirm the correct diagnosis might be an intraocular biopsy. The present work focuses on the leading symptoms, differential diagnoses and clinical signs of UMS | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Rating, Philipp |e verfasserin |4 aut | |
| 700 | 1 | |a Bechrakis, Nikolaos E |e verfasserin |4 aut | |
| 700 | 1 | |a Lommatzsch, Albrecht Peter |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Klinische Monatsblatter fur Augenheilkunde |d 1963 |g 237(2020), 5 vom: 01. Mai, Seite 614-620 |w (DE-627)NLM000020109 |x 1439-3999 |7 nnns |
| 773 | 1 | 8 | |g volume:237 |g year:2020 |g number:5 |g day:01 |g month:05 |g pages:614-620 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1055/a-1120-8787 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 237 |j 2020 |e 5 |b 01 |c 05 |h 614-620 | ||